• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期钠电流抑制剂作为潜在的抗心律失常药物。

Late Sodium Current Inhibitors as Potential Antiarrhythmic Agents.

作者信息

Horváth Balázs, Hézső Tamás, Kiss Dénes, Kistamás Kornél, Magyar János, Nánási Péter P, Bányász Tamás

机构信息

Department of Physiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Faculty of Pharmacy, University of Debrecen, Debrecen, Hungary.

出版信息

Front Pharmacol. 2020 Apr 20;11:413. doi: 10.3389/fphar.2020.00413. eCollection 2020.

DOI:10.3389/fphar.2020.00413
PMID:32372952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7184885/
Abstract

Based on recent findings, an increased late sodium current (I) plays an important pathophysiological role in cardiac diseases, including rhythm disorders. The article first describes what is I and how it functions under physiological circumstances. Next, it shows the wide range of cellular mechanisms that can contribute to an increased I in heart diseases, and also discusses how the upregulated I can play a role in the generation of cardiac arrhythmias. The last part of the article is about I inhibiting drugs as potential antiarrhythmic agents, based on experimental and preclinical data as well as in the light of clinical trials.

摘要

基于最近的研究发现,晚钠电流(I)增加在包括心律失常在内的心脏疾病中发挥着重要的病理生理作用。本文首先描述了什么是晚钠电流(I)以及它在生理情况下如何发挥作用。接下来,阐述了在心脏疾病中可导致晚钠电流(I)增加的多种细胞机制,还讨论了上调的晚钠电流(I)如何在心律失常的发生中发挥作用。本文的最后一部分是基于实验和临床前数据以及临床试验,探讨晚钠电流(I)抑制药物作为潜在抗心律失常药物的情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8105/7184885/03c2a94eb5b5/fphar-11-00413-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8105/7184885/a60131be7f7e/fphar-11-00413-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8105/7184885/03c2a94eb5b5/fphar-11-00413-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8105/7184885/a60131be7f7e/fphar-11-00413-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8105/7184885/03c2a94eb5b5/fphar-11-00413-g002.jpg

相似文献

1
Late Sodium Current Inhibitors as Potential Antiarrhythmic Agents.晚期钠电流抑制剂作为潜在的抗心律失常药物。
Front Pharmacol. 2020 Apr 20;11:413. doi: 10.3389/fphar.2020.00413. eCollection 2020.
2
The late sodium current in heart failure: pathophysiology and clinical relevance.心力衰竭中的晚钠电流:病理生理学及临床意义
ESC Heart Fail. 2014 Sep;1(1):26-40. doi: 10.1002/ehf2.12003.
3
Late INa Inhibition as an Antiarrhythmic Strategy.晚期钠电流抑制:一种抗心律失常策略。
J Cardiovasc Pharmacol. 2017 Sep;70(3):159-167. doi: 10.1097/FJC.0000000000000510.
4
Extracellular acidification reveals the antiarrhythmic properties of amiodarone related to late sodium current-induced atrial arrhythmia.细胞外酸化揭示了胺碘酮的抗心律失常特性,这与其诱导的晚期钠电流性心房心律失常有关。
Pharmacol Rep. 2024 Jun;76(3):585-599. doi: 10.1007/s43440-024-00597-2. Epub 2024 Apr 15.
5
Late sodium current and calcium homeostasis in arrhythmogenesis.钠电流延迟和钙稳态失衡与心律失常发生。
Channels (Austin). 2021 Dec;15(1):1-19. doi: 10.1080/19336950.2020.1854986.
6
An emerging antiarrhythmic target: late sodium current.一个新兴的抗心律失常靶点:晚钠电流。
Curr Pharm Des. 2015;21(8):1073-90. doi: 10.2174/1381612820666141029111729.
7
Voltage-Gated Sodium Channel Phosphorylation at Ser571 Regulates Late Current, Arrhythmia, and Cardiac Function In Vivo.丝氨酸571位点的电压门控钠通道磷酸化调节晚期电流、心律失常及体内心脏功能。
Circulation. 2015 Aug 18;132(7):567-77. doi: 10.1161/CIRCULATIONAHA.114.015218. Epub 2015 Jul 17.
8
The arrhythmogenic consequences of increasing late INa in the cardiomyocyte.增加心肌细胞晚期 INa 致心律失常的后果。
Cardiovasc Res. 2013 Sep 1;99(4):600-11. doi: 10.1093/cvr/cvt145. Epub 2013 Jun 10.
9
Eugenol interacts with cardiac sodium channel and reduces heart excitability and arrhythmias.丁香酚与心脏钠离子通道相互作用,降低心脏兴奋性和心律失常。
Life Sci. 2021 Oct 1;282:119761. doi: 10.1016/j.lfs.2021.119761. Epub 2021 Jul 1.
10
Late sodium current in human, canine and guinea pig ventricular myocardium.人心室、犬心室和豚鼠心室心肌中的晚钠电流。
J Mol Cell Cardiol. 2020 Feb;139:14-23. doi: 10.1016/j.yjmcc.2019.12.015. Epub 2020 Jan 17.

引用本文的文献

1
Safety and Short-Term Effects of Empagliflozin in Patients with Heart Failure and End-Stage Renal Disease.恩格列净在心力衰竭和终末期肾病患者中的安全性及短期疗效
Am J Cardiovasc Drugs. 2025 Aug 25. doi: 10.1007/s40256-025-00760-x.
2
Effects of open-channel blocking peptides in Na1.5 ΔKPQ.开放通道阻断肽对Na1.5 ΔKPQ的影响。
Biophys J. 2025 Jul 15;124(14):2263-2279. doi: 10.1016/j.bpj.2025.05.030. Epub 2025 Jun 2.
3
Eleclazine Suppresses Ventricular Fibrillation in Failing Rabbit Hearts with Ischemia-Reperfusion Injury Undergoing Therapeutic Hypothermia.

本文引用的文献

1
Late sodium current in human, canine and guinea pig ventricular myocardium.人心室、犬心室和豚鼠心室心肌中的晚钠电流。
J Mol Cell Cardiol. 2020 Feb;139:14-23. doi: 10.1016/j.yjmcc.2019.12.015. Epub 2020 Jan 17.
2
-Glycosylation of the voltage-gated sodium channel β2 subunit is required for efficient trafficking of Na1.5/β2 to the plasma membrane.电压门控钠离子通道β2 亚基的糖基化是 Na1.5/β2 有效转运到质膜所必需的。
J Biol Chem. 2019 Nov 1;294(44):16123-16140. doi: 10.1074/jbc.RA119.007903. Epub 2019 Sep 11.
3
Acquired Long QT Syndrome and Electrophysiology of Torsade de Pointes.
依来卡嗪可抑制接受亚低温治疗的伴有缺血-再灌注损伤的衰竭兔心脏的心室颤动。
Pharmacology. 2025;110(3):151-164. doi: 10.1159/000542292. Epub 2024 Oct 28.
4
From genes to clinical management: A comprehensive review of long QT syndrome pathogenesis and treatment.从基因到临床管理:长QT综合征发病机制与治疗的全面综述
Heart Rhythm O2. 2024 Jul 15;5(8):573-586. doi: 10.1016/j.hroo.2024.07.006. eCollection 2024 Aug.
5
New insights on cardiac Na channel block by an atypical anti-arrhythmic drug.一种非典型抗心律失常药物对心脏钠通道阻滞的新见解。
Nat Cardiovasc Res. 2023 Jun;2(6):494-495. doi: 10.1038/s44161-023-00284-0.
6
A Brief Introduction to Management of LQTS.长QT综合征管理简介
Rev Cardiovasc Med. 2022 May 5;23(5):164. doi: 10.31083/j.rcm2305164. eCollection 2022 May.
7
Na1.8 as Proarrhythmic Target in a Ventricular Cardiac Stem Cell Model.钠 1.8 作为心室心脏干细胞模型中的致心律失常靶点。
Int J Mol Sci. 2024 Jun 2;25(11):6144. doi: 10.3390/ijms25116144.
8
Ion channel trafficking implications in heart failure.离子通道转运在心力衰竭中的意义。
Front Cardiovasc Med. 2024 Feb 14;11:1351496. doi: 10.3389/fcvm.2024.1351496. eCollection 2024.
9
Store-Operated Ca Entry as a Putative Target of Flecainide for the Treatment of Arrhythmogenic Cardiomyopathy.作为氟卡尼治疗致心律失常性心肌病假定靶点的储存-操作性钙内流
J Clin Med. 2023 Aug 14;12(16):5295. doi: 10.3390/jcm12165295.
10
Potential favorable action of sodium-glucose cotransporter-2 inhibitors on sudden cardiac death: a brief overview.钠-葡萄糖协同转运蛋白2抑制剂对心源性猝死的潜在有利作用:简要概述
Front Cardiovasc Med. 2023 May 12;10:1159953. doi: 10.3389/fcvm.2023.1159953. eCollection 2023.
获得性长QT综合征与尖端扭转型室速的电生理学
Arrhythm Electrophysiol Rev. 2019 May;8(2):122-130. doi: 10.15420/aer.2019.8.3.
4
Arrhythmias due to Inherited and Acquired Abnormalities of Ventricular Repolarization.由遗传性和获得性心室复极异常引起的心律失常。
Card Electrophysiol Clin. 2019 Jun;11(2):345-362. doi: 10.1016/j.ccep.2019.02.009. Epub 2019 Apr 10.
5
The functional consequences of sodium channel Na 1.8 in human left ventricular hypertrophy.钠离子通道 Na1.8 在人类左心室肥厚中的功能后果。
ESC Heart Fail. 2019 Feb;6(1):154-163. doi: 10.1002/ehf2.12378. Epub 2018 Oct 30.
6
β-adrenergic regulation of late Na current during cardiac action potential is mediated by both PKA and CaMKII.β-肾上腺素能调节心脏动作电位中的晚期 Na 电流是由 PKA 和 CaMKII 共同介导的。
J Mol Cell Cardiol. 2018 Oct;123:168-179. doi: 10.1016/j.yjmcc.2018.09.006. Epub 2018 Sep 18.
7
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID Trial.雷米雷司在植入式心脏复律除颤器高危患者中的应用:RAID 试验。
J Am Coll Cardiol. 2018 Aug 7;72(6):636-645. doi: 10.1016/j.jacc.2018.04.086.
8
Differential regulation of sodium channels as a novel proarrhythmic mechanism in the human failing heart.钠离子通道差异调控致人心力衰竭心律失常发生的新机制
Cardiovasc Res. 2018 Nov 1;114(13):1728-1737. doi: 10.1093/cvr/cvy152.
9
RNA Binding Protein, HuR, Regulates Expression Through Stabilizing MEF2C transcription factor mRNA.RNA 结合蛋白 HuR 通过稳定 MEF2C 转录因子 mRNA 来调节 表达。
J Am Heart Assoc. 2018 Apr 20;7(9):e007802. doi: 10.1161/JAHA.117.007802.
10
Selective late sodium current inhibitor GS-458967 suppresses Torsades de Pointes by mostly affecting perpetuation but not initiation of the arrhythmia.选择性延迟钠电流抑制剂 GS-458967 通过主要影响心律失常的持续而不是起始来抑制尖端扭转型室性心动过速。
Br J Pharmacol. 2018 Jun;175(12):2470-2482. doi: 10.1111/bph.14217. Epub 2018 May 6.